Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture

Biotechnology Progress

Volumn 29, Issue 3, 2013, Pages 745-753

  Read, Erik K ^a   Bradley, Scott A ^b   Smitka, Tim A ^b   Agarabi, Cyrus D ^a   Lute, Scott C ^a   Brorson, Kurt A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Antibody; Bioreactor; Fermentanomics; Glycans; Hybridoma; Monoclonal

Indexed keywords

AMINO ACID SUPPLEMENTATION; ANTIBODY PRODUCTION; FERMENTANOMICS; GLYCANS; HYBRIDOMA; MAMMALIAN CELL CULTURE; MONOCLONAL; QUALITY ATTRIBUTES;

ANTIBODIES; BIOREACTORS; CELL CULTURE; POLYSACCHARIDES;

AMINO ACIDS;

AMINO ACID; ANTIBODY; POLYSACCHARIDE;

ANIMAL; ARTICLE; BIOREACTOR; BIOTECHNOLOGY; CULTURE MEDIUM; FERMENTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYBRIDOMA; METABOLISM; METHODOLOGY; MOUSE;

AMINO ACIDS; ANIMALS; ANTIBODIES; BIOREACTORS; BIOTECHNOLOGY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA; FERMENTATION; HYBRIDOMAS; MICE; POLYSACCHARIDES;

MAMMALIA;

EID: 84879259694     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1728     Document Type: Article

References (41)

1. Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov. 2010;9:767-774.
2. Chong WPK, Reddy SG, Yusufi FNK, Lee D-Y, Wong NSC, Heng CK, Yap MGS, Ho YS. Metabolomics-driven approach for the improvement of Chinese hamster ovary cell growth: overexpression of malate dehydrogenase II. J Biotechnol. 2010;147:116-121.
3. Jeong D-W, Cho IT, Kim TS, Bae GW, Kim I-H, Kim IY. Effects of lactate dehydrogenase suppression and glycerol-3-phosphate dehydrogenase overexpression on cellular metabolism. Mol Cell Biochem. 2006;284:1-8.
4. Bianchi AA, McGrew JT. High-level expression of full-length antibodies using trans-complementing expression vectors. Biotechnol Bioeng. 2003;84:439-444.
5. Wong ET, Kolman JL, Li Y-C, Mesner LD, Hillen W, Berens C, Wahl GM. Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange. Nucleic Acids Res. 2005;33:147-160.
6. Zhou H, Liu Z-G, Sun Z-W, Huang Y, Yu W-Y. Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. J Biotechnol. 2010;147:122-129.
7. Müller D, Katinger H, Grillari J. MicroRNAs as targets for engineering of CHO cell factories. Trends Biotechnol. 2008;26:359-365.
8. Fox SR, Tan HK, Tan MC, Wong SCNC, Yap MGS, Wang DIC. A detailed understanding of the enhanced hypothermic productivity of interferon-γ by Chinese-hamster ovary cells. Biotechnol Appl Biochem. 2005;41:225-264.
9. Moore A, Mercer J, Dutina G, Donahue CJ, Bauer KD, Mather JP, Etcheverry T, Ryll T. Effects of temperature shift on cell cycle, apoptosis and nucleotide pools in CHO cell batch cultures. Cytotechnology 1997;23:47-54.
10. Allen MJ, Boyce JP, Trentalange MT, Treiber DL, Rasmussen B, Tillotoson B, Davis R, Reddy P. Identification of novel small molecule enhancers of protein production by cultured mammalian cells. Biotechnol Bioeng. 2008;100:1193-1204.
11. Sung YH, Lee GM. Enhanced human thrombopoietin production by sodium butyrate addition to serum-free suspension culture of Bcl-2-overexpressing CHO cells. Biotechnol Prog. 2005;21:50-57.
12. Zhu MM, Goyal A, Rank DL, Gupta SK, Boom TV, Lee SS. Effects of elevated pCO2 and osmolality on growth of CHO cells and production of antibody-fusion protein B1: a case study. Biotechnol Prog. 2005;21:70-77.
13. Dowd JE, Kwok KE, Piret JM. Glucose-based optimization of CHO-cell perfusion cultures. Biotechnol Bioeng. 2001;75:252-256.
14. Ma N, Ellet J, Okediadi C, Hermes P, McCormick E, Casnocha S. A single nutrient feed supports both chemically defined NS0 and CHO fed-batch processes: improved productivity and lactate metabolism. Biotechnol Prog. 2009;25:1353-1363.
15. Khattak SF, Xing Z, Kenty B, Koyrakh I, Li ZJ. Feed development for fed-batch CHO production process by semisteady state analysis. Biotechnol Prog. 2010;26:797-804.
16. Li B, Ryan PW, Ray BH, Leister KJ, Sirimuthu NM, Ryder AG. Rapid characterization and quality control of complex cell culture media solutions using raman spectroscopy and chemometrics. Biotechnol Bioeng. 2010;107:290-301.
17. Abu-Absi NR, Kenty BM, Cuellar ME, Borys MC, Sakhamuri S, Strachan DJ, Hausladen MC, Li ZJ. Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in-line Raman spectroscopy probe. Biotechnol Bioeng. 2011;108:1215-1221.
18. Ryan PW, Li B, Shanahan M, Leister KJ, Ryder AG. Prediction of cell culture media performance using fluorescence spectroscopy. Anal Chem. 2010;82:1311-1317.
19. Bradley SA, Ouyang A, Purdie J, Smitka TA, Wang T, Kaerner A. Fermentanomics: monitoring mammalian cell cultures with NMR spectroscopy. J Am Chem Soc. 2010;132:9531-9533.
20. Chong WP, Goh LT, Reddy SG, Yusufi FN, Lee DY, Wong NS, Heng CK, Yap MG, Ho YS. Metabolomics profiling of extracellular metabolites in recombinant Chinese Hamster ovary fed-batch culture. Rapid Commun Mass Spectrom. 2009;23:3763-3771.
21. Khetan A, Huang YM, Dolnikova J, Pederson NE, Wen D, Yusuf-Makagiansar H, Chen P, Ryll T. Control of misincorporation of serine for asparagine during antibody production using CHO cells. Biotechnol Bioeng. 2010;107:116-123.
22. Yu M, Hu Z, Pacis E, Vijayasankaran N, Shen A, Li F. Understanding the intracellular effect of enhanced nutrient feeding toward high titer antibody production process. Biotechnol Bioeng. 2011;108:1078-1088.
23. Feeney L, Carvalhal V, Christopher-Yu X, Chan B, Michels D, Wang Y, Shen A, Ressl J, Dusel B, Laird M. Eliminating tyrosine sequence variants in CHO cell lines producing recombinant monoclonal antibodies. Biotech. Bioeng. 2013;DOI 10.1002/bit.24759.
24. Rubenstein LJ, Stein KE. Murine immune response to the Neisseria meningitidis Group C capsular polysaccharide II. Specificity. J Immunol. 1988;141:4357-4362.
25. Royle L, Radcliffe, CM, Dwek RA, Rudd PM. Glycobiology protocols. In Brockhausen-Schutzbach I, editor. Methods in Molecular Biology. NJ: Humana Press; 2006:125-144.
26. Vallejos JR, Uplekar S, da Silva JF, Brorson KA, Moreira AR, Rao G. A case study in converting disposable process scouting devices into disposable bioreactors as a future bioprocessing tool. Biotechnol Bioeng. 2012;109:2790-2797.
27. Hanson MA, Ge X, Kostov Y, Brorson KA, Moreira AR, Rao G. Comparisons of optical pH and dissolved oxygen sensors with traditional electrochemical probes during mammalian cell culture. Biotechnol Bioeng. 2007;97:833-841.
28. Kondragunta B, Drew JL, Brorson KA, Moreira AR, Rao G. Advances in clone selection using high-throughput bioreactors. Biotechnol Prog. 2010;26:1095-1103.
29. Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A. Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotech. Gen. Eng. Rev. 2012;28:147-176.
30. Read EK, Park JT, Brorson KA. Industry and regulatory experience of the glycosylation of monoclonal antibodies. Biotechnol Appl Biochem. 2011;58:213-219.
31. Henderson JW, Ricker RD, Bidlingmeyer BA, Woodward C. Amino acid analysis using Zorbax Eclipse-AAA and the Agilent 1100 HPLC. 2006 Agilent Technical Note #5980-1193EN.
32. Niwa R, Natsume A, Uehara A, Wakitani M, Iida S, Uchida K, Satoh M, Shitara K. IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides. J Immunol Methods. 2005;306:151-160.
33. Raju TS. 2008. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr Opin Immunol. 2008;20:471-478.
34. Kunkel JP, Jan DC, Butler M, Jamieson JC. Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors. Biotechnol Prog. 2000;16:462-470.
35. Müthing J, Kemminer SE, Conradt HS, Sagi D, Nimtz M, Kärst U, Peter-Katalinić J. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24. Biotechnol Bioeng. 2003;83:321-334.
36. Chen P, Harcum SW. Effects of amino acid additions on ammonium stressed CHO cells. J Biotechnol. 2005;117:277-286.
37. Wong D, Wong, K, Goh L, Heng C, Yap, M. Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotech Bioeng. 2005;89:164-177.
38. Hodoniczky J, Zheng YZ, James DC. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol Prog. 2005;21:1644-1652.
39. Young VR. Adult amino acid requirements: the case for a major revision in current recommendations. J Nutr. 1994;124(8 Suppl):1517S-1523S.
40. Kim do Y, Chaudry MA, Kennard ML, Jardon MA, Braasch K, Dionne B, Butler M, Piret JM. Fed-batch CHO cell t-PA production and feed glutamine replacement to reduce ammonia production. Biotechnol Prog. 2013;29:165-175.
41. Read EK, Park JT, Shah RB, Riley BS, Brorson KA, Rathore AS. Process analytical technology (PAT) for biopharmaceutical products. I. concepts and applications. Biotechnol Bioeng. 2010;105:276-284.